XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Preferred Stock
Preferred Stock
Preferred Stock
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at the beginning of the period (in shares) at Dec. 31, 2019     0   2,486,000 [1]        
Balance at the beginning of the period at Dec. 31, 2019 $ 3,996   $ 0   $ 0 $ 128,873   $ (3) $ (124,874)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee stock option and stock purchase plans (in shares) [1]         5,000        
Issuance of common stock under employee stock option and stock purchase plans 0                
Offering costs on issuance of common stock and warrants (474)         (474)      
Warrant liability (1,636)         (1,636)      
Issuance of common stock and warrants (in shares) [1]         688,000        
Issuance of common stock and warrants 2,749         2,749      
Conversion of notes to preferred stock (in shares)       2,709,000          
Conversion of notes to preferred stock   $ 1,769         $ 1,769    
Stock-based compensation 20         20      
Net loss (541)               (541)
Balance at the end of the period (in shares) at Mar. 31, 2020     2,709,000   3,179,000 [1]        
Balance at the end of the period at Mar. 31, 2020 5,883   $ 0   $ 0 131,301   (3) (125,415)
Balance at the beginning of the period (in shares) at Dec. 31, 2019     0   2,486,000 [1]        
Balance at the beginning of the period at Dec. 31, 2019 3,996   $ 0   $ 0 128,873   (3) (124,874)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (6,046)                
Balance at the end of the period (in shares) at Sep. 30, 2020     2,597,000   3,428,000 [1],[2]        
Balance at the end of the period at Sep. 30, 2020 2,139   $ 0   $ 0 133,062   (3) (130,920)
Balance at the beginning of the period (in shares) at Mar. 31, 2020     2,709,000   3,179,000 [1]        
Balance at the beginning of the period at Mar. 31, 2020 5,883   $ 0   $ 0 131,301   (3) (125,415)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee stock option and stock purchase plans (in shares) [1]         0        
Issuance of common stock under employee stock option and stock purchase plans 30         30      
Issuance of common stock upon the exercise of warrants (in shares) [1]         15,000        
Issuance of common stock upon the exercise of warrants 103         103      
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units (3)         (3)      
Conversion of notes to preferred stock (in shares)     112,000   22,000 [1]        
Stock-based compensation 41         41      
Net loss (4,340)               (4,340)
Balance at the end of the period (in shares) at Jun. 30, 2020     2,597,000   3,216,000 [1]        
Balance at the end of the period at Jun. 30, 2020 1,714   $ 0   $ 0 131,472   (3) (129,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee stock option and stock purchase plans (in shares) [1]         30,000        
Issuance of common stock under employee stock option and stock purchase plans 0         0      
Issuance of common stock upon the exercise of warrants (in shares) [1]         182,000        
Issuance of common stock upon the exercise of warrants 1,555         1,555      
Stock-based compensation 35         35      
Net loss (1,165)               (1,165)
Balance at the end of the period (in shares) at Sep. 30, 2020     2,597,000   3,428,000 [1],[2]        
Balance at the end of the period at Sep. 30, 2020 2,139   $ 0   $ 0 133,062   (3) (130,920)
Balance at the beginning of the period (in shares) at Dec. 31, 2020     2,597,000   3,525,000        
Balance at the beginning of the period at Dec. 31, 2020 4,255   $ 0   $ 0 135,113   (3) (130,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee stock option and stock purchase plans (in shares)         1,000        
Issuance of common stock under employee stock option and stock purchase plans 0                
Issuance of common stock upon the exercise of warrants (in shares)         156,000        
Issuance of common stock upon the exercise of warrants 527         527      
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units (in shares)         0        
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units (2)         (2)      
Stock-based compensation 140         140      
Net loss (1,642)               (1,642)
Balance at the end of the period (in shares) at Mar. 31, 2021     2,597,000   3,682,000        
Balance at the end of the period at Mar. 31, 2021 3,278   $ 0   $ 0 135,778   (3) (132,497)
Balance at the beginning of the period (in shares) at Dec. 31, 2020     2,597,000   3,525,000        
Balance at the beginning of the period at Dec. 31, 2020 $ 4,255   $ 0   $ 0 135,113   (3) (130,855)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of warrants (in shares) 156,446                
Net loss $ (5,255)                
Balance at the end of the period (in shares) at Sep. 30, 2021     876,000   5,087,000        
Balance at the end of the period at Sep. 30, 2021 4,502   $ 0   $ 0 140,615   (3) (136,110)
Balance at the beginning of the period (in shares) at Mar. 31, 2021     2,597,000   3,682,000        
Balance at the beginning of the period at Mar. 31, 2021 3,278   $ 0   $ 0 135,778   (3) (132,497)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee stock option and stock purchase plans (in shares)         69,000        
Issuance of common stock under employee stock option and stock purchase plans 59         59      
Offering costs on issuance of common stock and warrants (469)         (469)      
Issuance of common stock and warrants (in shares)         990,000        
Issuance of common stock and warrants 5,000         5,000      
Conversion of notes to preferred stock (in shares)     1,721,000   344,000        
Stock-based compensation 208         208      
Net loss (2,473)               (2,473)
Balance at the end of the period (in shares) at Jun. 30, 2021     876,000   5,085,000        
Balance at the end of the period at Jun. 30, 2021 5,603   $ 0   $ 0 140,576   (3) (134,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee stock option and stock purchase plans (in shares)         2,000        
Issuance of common stock under employee stock option and stock purchase plans 0                
Offering costs on issuance of common stock and warrants (1)         (1)      
Common stock withheld in lieu of income tax withholding on vesting of restricted stock units 1         1      
Stock-based compensation 39         39      
Net loss (1,140)               (1,140)
Balance at the end of the period (in shares) at Sep. 30, 2021     876,000   5,087,000        
Balance at the end of the period at Sep. 30, 2021 $ 4,502   $ 0   $ 0 $ 140,615   $ (3) $ (136,110)
[1] Shares outstanding for prior periods have been restated for the 1-for-5 reverse stock split effective June 11, 2020.
[2] * Shares outstanding for the nine months ended September 30, 2020 have been restated for the 1-for-5 reverse stock split effective June 11, 2020.